Total lymphoid irradiation in patients with refractory rheumatoid arthritis.
Eleven patients with rheumatoid arthritis that had been refractory to conventional drug therapy were treated with total lymphoid irradiation (TLI). Followup continued for 6 months in 9 patients, 12 months in 6 patients, and 24 months in 3 patients. At 6 and 12 months post-TLI, a significant improvement in clinical disease activity was demonstrated. Side effects noted during TLI included fatigue, nausea, diarrhea, and vomiting. One patient died of cardiorespiratory arrest, 2 patients died of kidney failure secondary to generalized amyloidosis, and 1 patient died of septic shock secondary to a multilocular septic arthritis. One patient experienced 2 episodes of septic arthritis; 2 patients manifested delayed wound healing. Immunologic assessments showed consistent lymphopenia in all patients. T lymphocyte subsets decreased after TLI, and showed a transient increase at 6 months post-TLI. The suppressed mitogen responsiveness, which was noted 2 months after irradiation, was found to increase almost to the pre-TLI levels at 12 months. The observed increase in morbidity and mortality after TLI is evidence that discourages the use of this therapeutic technique, at least in its present form.
Nüsslein
H G
HG
Herbst
M
M
Manger
B J
BJ
Gramatzki
M
M
Burmester
G R
GR
Fritz
H
H
Sauer
R
R
Kalden
J R
JR
D000936:Antigen-Antibody Complex / Q000032:analysis; D001172:Arthritis, Rheumatoid / Q000532:radiotherapy*; D001402:B-Lymphocytes; D006323:Heart Arrest / Q000150:complications; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007165:Immunosuppression Therapy; D007958:Leukocyte Count; D008214:Lymphocytes / Q000528:radiation effects*; D008221:Lymphoid Tissue / Q000528:radiation effects*; D010490:Pericardial Effusion / Q000150:complications; D012217:Rheumatoid Factor / Q000032:analysis; D012772:Shock, Septic / Q000150:complications; D050378:T-Lymphocytes, Regulatory; D013997:Time Factors
D000936:Antigen-Antibody Complex; D007136:Immunoglobulins; D012217:Rheumatoid Factor